Easterly Investment Partners LLC Pacira Bio Sciences, Inc. Transaction History
Easterly Investment Partners LLC
- $1.25 Billion
- Q4 2024
A detailed history of Easterly Investment Partners LLC transactions in Pacira Bio Sciences, Inc. stock. As of the latest transaction made, Easterly Investment Partners LLC holds 105,651 shares of PCRX stock, worth $2.48 Million. This represents 0.16% of its overall portfolio holdings.
Number of Shares
105,651
Previous 134,484
21.44%
Holding current value
$2.48 Million
Previous $2.03 Million
1.73%
% of portfolio
0.16%
Previous 0.17%
Shares
6 transactions
Others Institutions Holding PCRX
# of Institutions
260Shares Held
49.8MCall Options Held
1.03MPut Options Held
139K-
Black Rock Inc. New York, NY8.01MShares$188 Million0.01% of portfolio
-
Vanguard Group Inc Valley Forge, PA5.26MShares$124 Million0.0% of portfolio
-
Pacer Advisors, Inc. Malvern, PA3.26MShares$76.7 Million0.15% of portfolio
-
D. E. Shaw & Co., Inc. New York, NY2.26MShares$53.1 Million0.03% of portfolio
-
Jim Simons Renaissance Technologies LLC | New York, Ny1.99MShares$46.8 Million0.06% of portfolio
About Pacira BioSciences, Inc.
- Ticker PCRX
- Exchange NASDAQ
- Sector Healthcare
- Industry Drug Manufacturers—Specialty & Generic
- Shares Outstandng 45,824,200
- Market Cap $1.08B
- Description
- Pacira BioSciences, Inc. provides non-opioid pain management and regenerative health solutions for healthcare practitioners and their patients in the United States. The company offers EXPAREL, a bupivacaine liposome injectable suspension; ZILRETTA, a triamcinolone acetonide extended-release injectable suspension; and iovera system, a non-opioid ...